ClinicalTrials.Veeva

Menu

Reduction of Seroma and Improvement of QoL in Breast Reconstruction With Tissue Expander

U

University of Foggia

Status

Completed

Conditions

Quality of Life
Safety Issues

Treatments

Procedure: breast drain removal

Study type

Interventional

Funder types

Other

Identifiers

NCT04188821
01/2019

Details and patient eligibility

About

The experimental hypothesis of this randomized controlled study was to demonstrate that early drain removal in patients who underwent immediate breast reconstruction with tissue expander is a safety procedure to improving clinical outcomes and quality of life (QoL). The mechanism of action underlying the proposed approach was intuitive. The early drain removal allows to: 1) avoid continuous seroma development caused by active suction of drain (stopping the circle "drain itself may perpetuate the drainage" with vacuum mechanism); 2) reduce the risks connected to "foreign body reaction" as tissue inflammation and infection; 3) improve QoL reducing pain, length of hospital stay and limitations of daily activities.

Enrollment

124 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • SNS (skin nipple sparing) or SS (skin sparing) mastectomy for breast cancer and immediate positioning of breast expander (without mesh) with placement of suction drain, regardless of TNM classification

Exclusion criteria

  • skin reducing mastectomy, reconstruction with flap, direct to implant reconstruction (with or without mesh or ADM) and axillary dissection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

124 participants in 2 patient groups

output based group
Active Comparator group
Description:
Investigators remove the drains when the suction drain flow was less than 30 ml/day for at least 2 days with no further signs of infection, fluid collection or impaired wound healing
Treatment:
Procedure: breast drain removal
early-removal group
Experimental group
Description:
Investigators remove the drains at hospital discharge, 3-4 days after surgery, regardless of the output at that time
Treatment:
Procedure: breast drain removal

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems